33O A phase I study to evaluate safety, pharmacokinetics (PK), and preliminary efficacy of CYH33, a phosphatidylinositol 3-kinase α (PI3Kα) inhibitor, in patients (pts) with advanced solid tumours
Titel:
33O A phase I study to evaluate safety, pharmacokinetics (PK), and preliminary efficacy of CYH33, a phosphatidylinositol 3-kinase α (PI3Kα) inhibitor, in patients (pts) with advanced solid tumours
Auteur:
Wei, X-L. Liu, J-H. Zhao, H. Zhang, Y. Liu, Q-W. Zou, B-Y. Wang, F. Wang, Z-Q. Qiu, M-Z. Yu, Q-Q. Du, Y-W. Xu, R-H.